Publication | Closed Access

Enhancing chemosensitivity of wild-type and drug-resistant MDA-MB-231 triple-negative breast cancer cell line to doxorubicin by silencing of STAT 3, Notch-1, and β-catenin genes

Breast Oncologyβ-Catenin GenesMedicinePharmacologyTumor ImmunityCancer Cell BiologyStat 3Breast CancerCancer BiologyAnti-cancer AgentCancer TreatmentOncologyCell BiologyCancer ResearchTumor Biology